INTRODUCTION: Astragalus mongholicus bunge and Angelica sinensis are botanical drugs rich in beneficial nutrients and health-promoting metabolites. Their roots can be decocted to a botanical drug decoction "Danggui Buxue Tang (DBT)," demonstrating human anti-inflammatory. METHODS: Here, we evaluate the mitigating function of DBT on lung inflammation and early fibrosis in a rat model. The model was established by tracheal dripping of silica suspension for 28 days. Positive intervention effects of DBT were observed in a dose-dependent manner after consecutive gavage of DBT (1.9, 3.8, and 7.6 g/kg·bw/d) for 28 days and 42 days. To explore the underlying molecular mechanism. DBT metabolites were profiled using a liquid chromatograph-mass spectrometer and the Chemspider database. RESULTS: Lung inflammation and fibrosis were confirmed using functional tests and histopathologic analysis. Metabolite target analysis identified nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (NOX4) as a key target of DBT in regulating pulmonary fibrosis. Gene ontology (GO) analysis estimated that oxidative stress, inflammatory response, myofibroblast differentiation, and extracellular matrix (ECM) deposition were the major target pathways of DBT. KEGG analysis found that DBT might modulate pulmonary fibrosis through the transforming growth factor-β (TGF-β) pathway. GO chord and signaling pathway maps revealed that NOX4 contributes to oxidative stress, inflammatory response, and TGF-β pathway regulation. The in vivo analyses confirmed that DBT significantly reduces NOX4 protein expression, inhibits oxidative stress and inflammatory responses, and reduces TGF-β1, p-SMAD3, fibronectin 1 (FN1), and smooth muscle actin (α-SMA) protein expression. DISCUSSION: These findings demonstrate the lung-protecting function of DBT in a rat model and identify critical target proteins associated with the underlying mechanism.
Astragalus mongholicus bunge and Angelica sinensis botanical drug decoction mitigates lung inflammation through NOX4/TGF-β1/SMAD3 signaling.
黄芪和当归的药用煎剂通过 NOX4/TGF-β1/SMAD3 信号通路减轻肺部炎症
阅读:7
作者:Yang Zhifeng, Chang Yuqian, Zhou Tong, Sui Wenwen, Dai Ping, Wei Yuan, Wang Jia-Sheng, Zhou Jun, Wen Chengli, Zhang Haidong
| 期刊: | Frontiers in Pharmacology | 影响因子: | 4.800 |
| 时间: | 2025 | 起止号: | 2025 Mar 26; 16:1565569 |
| doi: | 10.3389/fphar.2025.1565569 | 研究方向: | 免疫/内分泌 |
| 信号通路: | TGF-β | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
